Clinical trial
Pilot Study of an Implantable Microdevice for in Situ Evaluation of Drug Response in Renal Cell Carcinoma
NCT05700461 is registered in ClinicalTrials.gov with Oliver Jonas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of an Implantable Microdevice for in Situ Evaluation of Drug Response in Renal Cell Carcinoma
- Lead sponsor
- Oliver Jonas
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 1, 2024
- Completion date
- August 31, 2029
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer, metastatic renal cell carcinoma, renal cell carcinoma